Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ingredion (INGR) Common Equity (2016 - 2026)

Ingredion filings provide 17 years of Common Equity readings, the most recent being $4.3 billion for Q4 2025.

  • On a quarterly basis, Common Equity rose 12.91% to $4.3 billion in Q4 2025 year-over-year; TTM through Dec 2025 was $4.3 billion, a 12.91% increase, with the full-year FY2025 number at $4.3 billion, up 12.91% from a year prior.
  • Common Equity hit $4.3 billion in Q4 2025 for Ingredion, up from $4.3 billion in the prior quarter.
  • In the past five years, Common Equity ranged from a high of $5.4 billion in Q2 2025 to a low of -$1.2 billion in Q1 2024.
  • Median Common Equity over the past 5 years was $583.5 million (2021), compared with a mean of $1.4 billion.
  • Biggest five-year swings in Common Equity: skyrocketed 15230.77% in 2022 and later plummeted 1919.57% in 2024.
  • Ingredion's Common Equity stood at $3.9 billion in 2021, then crashed by 129.44% to -$1.1 billion in 2022, then skyrocketed by 95.82% to -$48.0 million in 2023, then soared by 8025.0% to $3.8 billion in 2024, then grew by 12.91% to $4.3 billion in 2025.
  • The last three reported values for Common Equity were $4.3 billion (Q4 2025), $4.3 billion (Q3 2025), and $5.4 billion (Q2 2025) per Business Quant data.